Results 271 to 280 of about 6,410,935 (343)

Heterotropic regulation and negative homotropic cooperativity

open access: yesFEBS Open Bio, EarlyView.
We identified a structural module common to some proteins that couple negative cooperativity with heterotropic regulation, two features that rarely coexist. These proteins are ring‐like and present an ordered asymmetry whereby noncontacting subunits are symmetric, and their tertiary structure differs from that of contacting subunits.
Veronica Morea   +5 more
wiley   +1 more source

Salmonella enterica serovar typhi limits the potency of typhoid toxin and ADP‐ribosylating toxin AB to establish a persistent infection

open access: yesFEBS Open Bio, EarlyView.
The two catalytic subunits of typhoid toxin dissociate from the holotoxin in the ER of an intoxicated cell, but only CdtB exits the ER to generate immunosuppressive effects. PltA is retained in the ER and sequestered from its cytosolic target, thus allowing the anti‐inflammatory effects of CdtB to promote intestinal colonization.
Maria C. Zabala‐Rodriguez   +4 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Flavivirus Entry Inhibitors

2022
Flaviviruses, including Dengue virus, Zika virus, Yellow fever virus, Japanese encephalitis virus, West Nile virus, cause thousands of deaths and millions of illnesses each year. The large outbreak of ZIKV in 2016 reminds us that flaviviruses can pose a serious threat to human safety and public health as emerging and re-emerging viruses. However, there
Yufeng, Yu, Lulu, Si, Yu, Meng
openaire   +2 more sources

Coronavirus Entry Inhibitors

2022
Coronaviruses (CoVs) are enveloped RNA viruses that widely exist in the environment. Several CoVs possess a strong ability to infect humans, termed as human coronavirus (HCoVs). Among seven known HCoVs, SARS-CoV-2, SARS-CoV, and MERS-CoV belong to highly pathogenic HCoVs, which can cause severe clinical symptoms and even death.
Qiaoshuai, Lan, Shuai, Xia, Lu, Lu
openaire   +2 more sources

HIV entry inhibitors

The Lancet, 2007
The need for new classes of antiretroviral drugs has become apparent because of increasing concern about the long-term toxic effects of existing drugs, the need to combat HIV-1 variants that are resistant to treatment, and the frequency of treatment change in drug-experienced patients.
José A, Esté, Amalio, Telenti
openaire   +4 more sources

COVID 19: Camostat and The Role of Serine Protease Entry Inhibitor TMPRSS2

, 2020
Citation: Bittmann S, Luchter E, Moschüring-Alieva E, Villalon G, Weissenstein A. COVID 19: Camostat and The Role of Serine Protease Entry Inhibitor TMPRSS2. J Regen Biol Med. 2020;2(2):12.
S. Bittmann
semanticscholar   +1 more source

Influenza Virus Entry inhibitors

2022
Influenza is a major challenge to health and the global economy. However, the increasing emergence of drug resistance during influenza pandemics cannot be ignored. It is particularly important to design and develop anti-influenza drugs with novel mechanisms of action for the treatment and prevention of influenza virus infections.
Jie, Yang, Shuwen, Liu
openaire   +2 more sources

Flavivirus Entry Inhibitors

ACS Infectious Diseases, 2015
Many flaviviruses are significant human pathogens that are transmitted by mosquitoes and ticks. Although effective vaccines are available for yellow fever virus, Japanese encephalitic virus, and tick-borne encephalitis virus, these and other flaviviruses still cause thousands of human deaths and millions of illnesses each year.
Qing-Yin, Wang, Pei-Yong, Shi
openaire   +2 more sources

Ebola Virus Entry Inhibitors

2022
Ebola virus (EBOV) is one of the most deadliest agents already known, causing periodic epidemic of a severe hemorrhagic fever disease in Africa. Although two monoclonal antibody (mAb) drugs have recently received approval in the USA, additional therapeutics are still needed to combat potential outbreaks of resistance variants and other closely related ...
Ruikun, Du   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy